Eric Merola on WABC National Radio

Watch/Listen here (Scroll down to 2nd video).

YOLA NASH INTERVIEWS Internationally award-winning documentary Film Director, Writer, Producer ERIC MEROLA who visits WABC. He sat down with WABC, New York’s Yola Nash for an interview to discuss his movies and the exciting scientific innovations. Merola is the director of the groundbreaking documentary series “Burzynski”, about a brilliant scientist who has discovered a non-toxic and gentle treatment for cancer. Don’t miss Eric Merola’s latest documentary, “The God Cells” – a story about a unique stem cell treatment that has the potential to change the face of medicine.

Eric Merola

Advertisements

See the leaked documents and other materials from the documentary “Second Opinion: Laetrile At Sloan-Kettering”

June 2, 1974 Laetrile Meeting with Top Leaders (Minutes)

On June 2, 1974 a meeting was held at The Food & Drug Administration (FDA) headquarters. The meeting’s purpose was to discuss conducting human clinical trials using Laetrile or similar “cyanide-releasing” substances based on the overwhelmingly positive lab studies conducted by Sloan-Kettering’s Dr. Kanematsu Sugiura.

These minutes were obtained via a “Freedom of Information Act” request.

Read: June 2, 1974 Minutes from Laetrile meeting at the FDA

After all attempts to get the attention of  mainstream journalists using these leaked documents, Ralph W. Moss, PhD packaged the documents up and sent them anonymously to “The Committee For Freedom Of Choice In Cancer Therapy” – which continued to distribute them in an attempt to alert the American public of this cover-up.

Read the leaked documents package here.

1977 Second Opinion Special Report: Laetrile At Sloan-Kettering

This 48-page document was written in the summer of 1977 by Ralph W. Moss, PhD and other anonymous rank-in-file employees of Sloan-Kettering. This report was written in response to the alleged “negative” findings of Sloan-Kettering’s Laetrile studies from 1973-1977. This document was also given to all in attendance of the November 1977 press conference held by Second Opinion.

Read the “Second Opinion Special Report: Laetrile At Sloan-Kettering Special” document here.

November 22, 1977 Letter to Second Opinion from Dr. Kanematsu Sugiura

While Ralph W. Moss, PhD was still an anonymous participant in Second Opinion, he sent his evaluation of Sloan-Kettering’s papers on their Laetrile studies (Special Report on Laetrile) to Dr. Sugiura, who was the lead scientist conducting the studies. This letter is Dr. Sugiura’s response to Ralph’s evaluation of his work and how Sloan-Kettering diabolically manipulated the positive data. The letter is addressed to Alec Pruchnicki, the only public “face” of Second Opinion at this time.

Read the Nov. 22, 1977 letter to Second Opinion from Dr. Sugiura

July 30, 1979 letter from Dr. Kanematsu Sugiura

Shortly after the release of this documentary, the film’s director was contacted by a man named John Pittman Hey, who had written to Dr. Sugiura regarding the laetrile cover-up back in 1979—and Dr. Sugiura responded. This is a very special and rare letter, and Mr. Hey has given us permission to post it here. It’s incredible how focused Dr. Sugiura was even at this late age – and how he steadfastly stood behind the results he found while testing Laetrile at Sloan-Kettering. It also shows what kind of man Dr. Sugiura was to write a handwritten 4-page letter to a total stranger. He wrote this letter 3 months before his death.

Read the July 30, 1979 letter from Dr. Sugiura to Mr. Hey

 

October 24, 1979 Letter to Ralph W. Moss, PhD from Linus Pauling

After Ralph was fired for exposing the Laetrile cover-up at Sloan-Kettering, he wrote a book about his experience called The Cancer Rebellion: Hope and Betrayal, that was to eventually become The Cancer Industry. Linus Pauling had some very strong words towards “The War On Cancer”.

Read the letter from Linus Pauling to Ralph W. Moss

1971 Congressional Testimony from the NCI’s Dr. Dean Burk

*This document is not included in Second Opinion, but it gives some insight to the political climate around Laetrile when the War On Cancer was first enacted. This is congressional testimony by Dr. Dean Burk, the head of the National Cancer Institute’s Cytochemistry Sector, with Congressman Symington.

Read the 1971 Congressional Testimony with Dr. Burk and Rep. Symington

 

German studies confirm Laetrile/Amygdalin’s anti-cancer properties

Watch the Q&A from “Second Opinion” here:

 

 

Read the peer-reviewed publications here:

August 2014:

Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0105590

 

Amygdalin Influences Bladder Cancer Cell Adhesion and InvasionIn Vitro

October 2014: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0110244

 

Challenge for the reader, try adding these verifiable links to the Wikipedia page for “Amygdalin” – they will not allow it! (Click here).

 

Maybe this is why 🙂 Watch this amazing TEDx lecture below:

 

 

Eric Merola – IMDB Biography

Eric Merola is an internationally award-winning documentary film director.

Before starting his career in documentary films, Eric began as a motions graphics designer and animator after founding “Merola Productions” and was commissioned by various clients including Fuel TV, WE Network, The Speed Channel, and Rolling Stone’s Matt Taibbi. He was also employed as an animation director for FlickerLab in New York City, where he worked on projects for Comedy Central and A&E.

In 2007, while directing an animated sequence for Michael Moore’s feature documentary, “Capitalism: A Love Story“, Eric began production on his first documentary, “Burzynski”, which garnered widespread distribution and won numerous international awards including “Best Documentary of 2011” on The Documentary Channel, two “Audience Awards” at the HumanDoc Film Festival in Warsaw and the “Humanitarian Vision Award” at the Newport Beach Film Festival. This film also received favorable reviews from various press including The Los Angeles Times and Variety, and granted Mr. Merola a guest appearance on The Dr. Oz Show.

Eric has since released a sequel to “Burzynski” in 2013 (“Burzynski: Cancer Is Serious Business, Part II“), which garnered even larger world-wide distribution, and took home the top Audience Award for Best Documentary at the Sedona Film Festival on March 2, 2014. While working on this sequel, he was also shooting and directing his third documentary, “Second Opinion: Laetrile At Sloan-Kettering“, which will have a theatrical release starting in eight major USA cities in the summer of 2014.

Visit Eric Merola Biography page on IMDB here. 

<blockquote class=”twitter-tweet” lang=”en”><p>Congratulations to Eric Merola, director of <a href=”https://twitter.com/hashtag/Burzynski?src=hash”>#Burzynski</a&gt; <a href=”https://twitter.com/hashtag/Cancer?src=hash”>#Cancer</a&gt; is Serious Business for winning the Audience Award from BEST of <a href=”https://twitter.com/DOC_Channel”>@DOC_Channel</a&gt;!</p>&mdash; Documentary Channel (@DOC_Channel) <a href=”https://twitter.com/DOC_Channel/statuses/156420405211561984″>January 9, 2012</a></blockquote>
<script async src=”//platform.twitter.com/widgets.js” charset=”utf-8″></script>

Watch BURZYNSKI: CANCER IS SERIOUS BUSINESS, PART II free on HULU!

Watch Burzynski Part II on Hulu!

Watch BURZYNSKI: CANCER IS SERIOUS BUSINESS, PART II free on HULU!

http://www.hulu.com/watch/571293

About the film:

In the compelling follow-up to the internationally award-winning documentary, Burzynski, the Movie; Burzynski: Cancer is Serious Business, Part II explores the current status of Antineoplastons’ clinical testing sanctioned by the United States Food & Drug Administration—and features a modern story of the struggling journeys of cancer patients being treated today at the Burzynski Clinic in Houston, Texas.

For most patients undergoing Burzynski’s treatment, their advanced cancer itself runs secondary to the constant barrage of skepticism coming not only from their local oncologists, but also from friends and family who feel their loved ones are making suspect treatment decisions—even though mainstream oncology has already left many for dead.

As the story unfolds, you will observe a real-time change of hearts and minds from many of these doctors and families. Unlike the first documentary, Part II showcases interviews with board-certified oncologists, surgeons and neurosurgeons, who witnessed patients leave their care, soon to return in great health after opting for the Burzynski Clinic.

Since the mapping of the Cancer Genome, Burzynski has pioneered an expansion of his therapy which he calls, “Personalized Gene-Targeted Cancer Therapy”, where each patient’s Genomic Cancer Atlas is mapped and a treatment regimen is personally tailored for each individual patient—vs. the conveyor belt, “one-size-fits-all” approach that current oncology adheres to.

Due to the slow-moving, bureaucratic obstacles enforced on Antineoplastons by America’s FDA, this new expanded “personalized gene-targeted” direction has allowed more patients (who are denied access to Antineoplastons) to benefit from Burzynski’s practice in ways never before thought possible. And yet, still with similar resistance and controversy endured by Burzynski’s Antineoplaston therapy.

The film also takes you to Kurume University in Fukuoka, Japan—where independently designed studies of Antineoplastons have been underway for 27 years—without Dr. Burzynski’s (the inventor’s) involvement or supervision. Learn how this team of Japanese pathologists, oncologists and surgeons have studied these anti-cancer co mpounds using their own methodologies—resulting in the first ever independently-run randomized controlled clinical trials.

“After twenty-seven years of independently testing Antineoplastons—including randomized clinical trials, we found that Dr. Burzynski was right. It’s obviously not anecdotal anymore.”
– Hideaki Tsuda, MD – 2013, Kurume Medical University, Fukuoka Prefecture, Japan

You will be placed into the turbulent journey of how the industry utilizes its now usurped regulatory agency to both block Antineoplastons’ Phase 3 clinical trial process—and orchestrate a group of “information hit men” (also known as an “Astroturf Campaign”) to pollute all channels of public information in an effort to confuse the public over the truth behind Antineoplastons. This international Astroturf group also engages in the intimidation and harassment of prospective and current terminal cancer patients under Dr. Burzynski’s care.

However, most notable of all—are the earth-shattering events that occurred upon the final days of production of this film—you’ll be left speechless, yet with so much to say, when you witness the story and shocking conclusion to Burzynski: Cancer Is Serious Business, Part II.

“I can’t imagine a world where other people will not have the privilege that I have had—the privilege to have their life saved by a new technology that can cure cancer—it’s terrifying.”

– Laura Hymas – 2013, Glioblastoma Grade IV brain cancer patient, after experiencing a complete remission under Antineoplaston therapy.

 

Follow director Eric Merola on Facebook

 

Eric Merola interviews former National Cancer Institute Scientist Dr. Li-Chuan Chen (VIDEO)

Eric Merola interviews former National Cancer Institute Scientist Dr. Li-Chuan Chen

Dr. Chen, formerly of the National Cancer Institute talks candidly about his work on Antineoplastons at the NCI, and his idea of our society needing a 2-party medical system for any real progress to be made in the War On Cancer.